Table 1.
Study cohort | No. of decedents | % | Study cohort | No. of decedents | % |
---|---|---|---|---|---|
Age group | Residence by Health Service Delivery Area (HSDA) | ||||
0-18 | 16 | 0.1 | Central Vancouver Island | 1,011 | 8.2 |
19-44 | 226 | 1.8 | East Kootenay | 239 | 1.9 |
45-64 | 2,327 | 18.9 | Fraser East | 807 | 6.6 |
65-74 | 2,511 | 20.4 | Fraser North | 1,346 | 10.9 |
75-84 | 3,613 | 29.4 | Fraser South | 1,619 | 13.2 |
85+ | 3,607 | 29.3 | Kootenay Boundary | 314 | 2.6 |
Sex | North Shore/Coast Garibal | 820 | 6.7 | ||
Female | 5,734 | 46.6 | North Vancouver Island | 421 | 3.4 |
Male | 6,566 | 53.4 | Northeast | 124 | 1.0 |
Primary cancer diagnosis | Northern Interior | 371 | 3.0 | ||
Lung | 2,406 | 19.6 | Northwest | 171 | 1.4 |
Breast | 1,204 | 9.8 | Okanagan | 1,289 | 10.5 |
Colorectal | 1,551 | 12.6 | Richmond | 376 | 3.1 |
Prostate | 1,438 | 11.7 | South Vancouver Island | 1,270 | 10.3 |
Non-colorectal GI | 1,454 | 11.8 | Thompson Cariboo Shuswap | 692 | 5.6 |
Blood | 938 | 7.6 | Vancouver | 1,405 | 11.4 |
Urinary | 656 | 5.3 | Missing | 25 | 0.2 |
Female Genital | 623 | 5.1 | Travel time (to closest cancer centre) | ||
Brain | 255 | 2.1 | ≤2 hours | 9,364 | 76.1 |
Melanoma | 265 | 2.2 | >2 hours | 2,911 | 23.7 |
Other | 1,510 | 12.3 | Radiotherapy (RT) | ||
Survival time from diagnosis | No RT | 9,341 | 75.9 | ||
<1.5 M | 1,812 | 14.7 | RT | 2,959 | 24.1 |
1.5-26 M | 5,085 | 41.3 | Palliative RT | 2,669 | 21.7 |
26 M+ | 5,403 | 43.9 | Nonpalliative RT | 290 | 2.4 |